Moreover, the number of TRAP-positive MNCs generated from PBMs treated with M-CSF, RANKL and TGFβ1 in healthy controls were significantly lower than those in patients with RA (p = 0.022, Figure 1e). This evidence concerns the gene TGFB1 and rheumatoid arthritis.